Thanks. I am confused a bit about CD. What percentage of the marker are the saying RVNC will get in that indication? As far as aesthetics, can they really believe sales of filler and Daxxify are linked in terms of percentage of the market? Shouldn't each be modeled separately?
As far as stock price, I bought some last week at the "bargain" price of $10.75. The stock is reacting today as if the FDA just failed to approve Daxxify in any indication. Quite amazing.